Overall, i like the company. I don't think there will be much news until next year. They are in the middle of the trial so updates on the total number of hospitals running the trials should be updated on the FDA clinical trials website. Once they dose 375 people I believe they can check the data for profound efficacy, and if it's present they can stop the trial early and go for approval.
It will play out exactly as it has done so many numerous times before. It pumps up for a couple few days and then drops right back down and continues toward sub penny status. If you look at the adjusted price taking into account the several reverse splits this is already below a penny a share. Like it or not this has become nothing more than a shell pumping out shares of worthless stock. Period.
News 
Market Data 
Discover 
